Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
Medical experts point to a growing body of research linking energy drinks to liver injury
The conclave brought together over 1,000 delegates from across India and internationally
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Subscribe To Our Newsletter & Stay Updated